AACR 2023 Conference Coverage


 

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With Gemcitabine & Cisplatin for Advanced Biliary Tract Cancer

352 views
May 10, 2023
Comments 1
Login to view comments. Click here to Login